Ocular Therapeutix (OCUL) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -103.57% |
| Dec 31, 2025 | -93.14% |
| Sep 30, 2025 | -41.79% |
| Jun 30, 2025 | -42.72% |
| Mar 31, 2025 | -33.97% |
| Dec 31, 2024 | -33.67% |
| Sep 30, 2024 | -33.57% |
| Jun 30, 2024 | -33.81% |
| Mar 31, 2024 | -32.13% |
| Dec 31, 2023 | 4.93% |
| Sep 30, 2023 | -16.10% |
| Jun 30, 2023 | 7.55% |
| Mar 31, 2023 | -17.96% |
| Dec 31, 2022 | -23.40% |
| Sep 30, 2022 | -22.74% |
| Jun 30, 2022 | -29.63% |
| Mar 31, 2022 | -24.01% |
| Dec 31, 2021 | -44.81% |
| Sep 30, 2021 | -46.64% |
| Jun 30, 2021 | -50.01% |
| Mar 31, 2021 | -49.30% |
| Dec 31, 2020 | -76.41% |
| Sep 30, 2020 | -11.35% |
| Jun 30, 2020 | -8.47% |
| Mar 31, 2020 | 15.70% |
| Dec 31, 2019 | 7.21% |
| Sep 30, 2019 | 4.77% |
| Jun 30, 2019 | 9.70% |
| Mar 31, 2019 | 7.21% |
| Dec 31, 2018 | 19.87% |
| Sep 30, 2018 | 20.61% |
| Jun 30, 2018 | 22.84% |
| Mar 31, 2018 | 2.28% |
| Dec 31, 2017 | 17.81% |
| Sep 30, 2017 | 14.16% |
| Jun 30, 2017 | -49.06% |
| Mar 31, 2017 | -84.73% |
| Dec 31, 2016 | -57.31% |
| Sep 30, 2016 | -51.89% |
| Jun 30, 2016 | -49.65% |